6-磷酸葡萄糖通过线粒体己糖激酶Ⅱ调控mTOR-自噬通路加重心肌细胞缺氧复氧损伤的机制OA
Glucose-6-phosphate exacerbates hypoxia/reoxygenation cardiomyocyte injury through the mtHK-Ⅱ-mTOR-autophagy axis
目的 探究6-磷酸葡萄糖(G6P)经线粒体己糖激酶Ⅱ(mtHK-Ⅱ)-mTOR-自噬通路调控缺氧/复氧(HR)心肌细胞损伤的机制.方法 H9C2心肌细胞HR模型(缺氧24 h/复氧2 h)分为N、HR、H G6P(HR+4-磷酸赤藓糖预处理)及H G6P+雷帕霉素(Rapa)4组.CCK-8法测活力;ELISA法测cTnT、CK、ATP及G6P浓度;透射电镜观察线粒体超微结构;Western blot检测mTOR/p-mTOR、Raptor、Beclin-1及LC3-Ⅱ/Ⅰ蛋白表达.结果 与N组相比,HR组活力下降、cTnT与CK升高,G6P堆积,mtHK-Ⅱ与ATP降低,p-mTOR/mTOR与Raptor下降(P<0.05);H G6P组G6P继续增加,线粒体损伤恶化,但mTOR反常回升、自噬受抑(P<0.05);H G6P+Rapa组mTOR抑制后自噬达峰值,心肌细胞损伤最重(P<0.001).结论 G6P堆积促使mtHK-Ⅱ脱落并抑制mTOR磷酸化,解除自噬负性调控,引起过度自噬加重心肌细胞缺氧复氧损伤.
Objective To investigate whether glucose-6-phosphate(G6P)regulates hypoxia/reoxygenation(HR)-induced cardiomyocyte injury via the mitochondrial hexokinase Ⅱ(mtHK-Ⅱ)-mTOR-autophagy axis.Methods H9C2 cardiomyocytes were subjected to HR(24 h hypoxia/2 h reoxygenation)and randomized into four groups:N,HR,H G6P(HR+erythrose-4-phosphate pretreatment),and H G6P+rapamycin(Rapa).Cell viability(CCK-8),cTnT,CK,ATP,and G6P(ELISA),mitochondrial ultrastructure(TEM),and mTOR/p-mTOR,Raptor,Beclin-1,and LC3-Ⅱ/Ⅰ(Western blot)were assessed.Results Compared with N group,HR group exhibited lower viability,elevated cTnT and CK,G6P accumulation,reduced mtHK-Ⅱ and ATP,decreased p-mTOR/mTOR and Raptor,and autophagy activation(P<0.05).H G6P group further ele-vated G6P and worsened mitochondrial injury,yet mTOR paradoxically rebounded and autophagy was suppressed(P<0.05).H G6P+Rapa group inhibited mTOR,maximized autophagy,and produced the severest cardio-myocyte injury(P<0.001).Conclusion G6P accumulation promotes mtHK-Ⅱ dissociation from mitochondria,inhibits mTOR phosphorylation,relieves autophagic suppression,and triggers excessive autophagy,thereby ag-gravates HR cardiomyocyte injury.
陈伟;胡永洪;王嫣;王海英
遵义医科大学附属医院麻醉科,贵州遵义 563000||遵义医科大学麻醉与器官保护教育部重点实验室(培育),贵州遵义 563000||贵州省麻醉与器官保护全省重点实验室,贵州遵义 563000遵义医科大学麻醉与器官保护教育部重点实验室(培育),贵州遵义 563000||贵州省麻醉与器官保护全省重点实验室,贵州遵义 563000||浙江省人民医院毕节医院(毕节市第一人民医院)麻醉科,贵州毕节 551700遵义医科大学附属医院麻醉科,贵州遵义 563000||遵义医科大学麻醉与器官保护教育部重点实验室(培育),贵州遵义 563000||贵州省麻醉与器官保护全省重点实验室,贵州遵义 563000遵义医科大学附属医院麻醉科,贵州遵义 563000||遵义医科大学麻醉与器官保护教育部重点实验室(培育),贵州遵义 563000||贵州省麻醉与器官保护全省重点实验室,贵州遵义 563000
医药卫生
6-磷酸葡萄糖线粒体己糖激酶ⅡmTOR自噬缺氧复氧损伤心肌细胞
glucose-6-phosphatemitochondrial hexokinase ⅡmTORautophagyhypoxia/reoxygenation injurycardiomyocyte
《遵义医科大学学报》 2026 (9)
975-985,11
国家自然科学基金资助项目(NO:82260057)贵州省临床重点专科建设项目(登峰计划)(NO:GZWJWDF2005006)贵州省卫健委2024年西南地区有影响力的重点优势学科培育项目(NO:xm040222).
评论